A molecular field-based similarity approach to pharmacophoric pattern recognition

Journal of Molecular Graphics and Modelling

Volumn 15, Issue 2, 1997, Pages 114-121

  Mestres, Jordi ^a,b   Rohrer, Douglas C ^a   Maggiora, Gerald M ^a  

^a Pharmacia and Upjohn Inc ^*  (United States)

^b UNIVERSITY OF GIRONA   (Spain)

Author keywords

filed based pharmacophoric patterns; Graphical similarity approaches; Molecular alignment; Molecular field similarity

Indexed keywords

CALCULATIONS; ENZYMES; MATHEMATICAL MODELS; MOLECULAR STRUCTURE; PATTERN RECOGNITION; THREE DIMENSIONAL;

BIOACTIVE MOLECULE; MOLECULAR ALIGNMENT; MOLECULAR FIELD SIMILARITY; PHARMACOPHORE MODEL; PROTEASE;

MOLECULES;

DRUG; PROTEINASE INHIBITOR;

ARTICLE; DRUG DESIGN; DRUG STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; PATTERN RECOGNITION; PRIORITY JOURNAL; STEREOSPECIFICITY;

EID: 0031126434     PISSN: 10933263     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1093-3263(97)00003-X     Document Type: Article

References (60)

1. Golender, V.E. and Vorpagel, E.R. Computer-assisted pharmacophore identification. In: 3D QSAR in Drug Design: Theory, Methods, and Applications (H. Kubinyi, ed.). Escom Science, Leiden, 1993, pp. 137-149
2. Liljefors, T. and Pettersson, I. Computer-aided development of three-dimensional pharmacophore models. In: A Textbook of Drug Design and Development (P. Krogsgaard-Larsen, T. Liljefors, and U. Madsen, eds.). Harwood Academic, Amsterdam, 1996, pp. 60-93
3. Martin, Y.C. 3D database searching in drug design. J. Med. Chem. 1992, 35, 2145-2154
4. Willett, P. Searching for pharmacophoric patterns in databases of three-dimensional chemical structures. J. Mol. Recogn. 1995, 8, 290-303
5. Johnson, M.A. and Maggiora, G.M. (eds.). Concepts and Applications of Molecular Similarity. Wiley, New York, 1990
6. Kubinyi, H. (ed.). 3D QSAR in Drug Design: Theory, Methods, and Applications. Escom Science, Leiden, 1993
7. Sen, K. (ed.). Topics in Current Chemistry: Molecular Similarity I, Vol. 173. Springer-Verlag, Berlin, 1995
8. Dean, P.M. (ed.). Molecular Similarity in Drug Design. Blackie Academic, London, 1995
9. Carbó, R. (ed.). Molecular Similarity and Reactivity: From Quantum Chemical to Phenomenological Approaches. Kluwer, Amsterdam, 1995
10. Van de Waterbeemd, H. (ed.). Structure-Property Correlations in Drug Research. Academic Press, London, 1996
11. Hopfinger, A.J. A QSAR investigation of dihydrofolate reductase inhibition by Baker triazines based upon molecular shape analysis. J. Am. Chem. Soc. 1980, 102, 7196-7206
12. Cramer, R.D., III, Patterson, D.E., and Bunce, J.D. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967
13. Good, A.C., So, S.-S., and Richards, W.G. Structure-activity relationships from molecular similarity matrices. J. Med. Chem. 1993, 36, 433
14. Klebe, G. Structural alignment of molecules. In: 3D QSAR in Drug Design. Theory, Methods, and Applications (H. Kubinyi, ed.). Escom Science, Leiden, 1993, pp. 173-199
15. Jakes, S.E. and Willett, P. Pharmacophoric pattern matching in files of three-dimensional chemical structures. Selection of interatomic distance screens. J. Mol. Graphics 1986, 4, 12-20
16. Perkins, T.D.J. and Dean, P.M. An exploration of a novel strategy for superposing several flexible molecules. J. Comput.-Aided Mol. Design 1993, 7, 155-172
17. Marshall, G.R., Barry, C.D., Bosshard, H.E., Dammkoehler, R.A., and Dunn, D.A. The conformational parameter in drug design: The active analogue approach. In: Computer-Assisted Drug Design (E.G. Olson and R.E. Christoffersen, eds.), Vol. 112. American Chemical Society, Washington, D.C., 1979, pp. 205-222
18. Mayer, D., Naylor, C.B., Motoc, I., and Marshall, G.R. A unique geometry of the active site of angiotensin-converting enzyme consistent with structure-activity studies. J. Comput.-Aided Mol. Design 1987, 1, 3-16
19. Van Drie, J.H., Weininger, D., and Martin, Y.C. ALADDIN: An integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional molecular structures. J. Comput.-Aided Mol. Design 1989, 3, 225-251
20. Jones, G., Willett, P., and Glen, R.C. A genetic algorithm for flexible molecular overlay and pharmacophore elucidation. J. Comput.-Aided Mol. Design 1995, 9, 532-549
21. Barnum, D., Greene, J., Smellie, A., and Sprague, P. Identification of common functional configurations among molecules. J. Chem. Inf. Comput. Sci. 1996, 36, 563-571
22. Chau, P.L. and Dean, P.M. Molecular recognition: 3D surface structure comparison by gnomonic projection. J. Mol. Graphics 1987, 5, 97-100
23. Tokarski, J.S. and Hopfinger, A.J. Three-dimensional molecular shape analysis - quantitative structure-activity relationship of a series of cholecystokinin-A receptor antagonists. J. Med. Chem. 1994, 37, 3639-3654
24. Jain, A.N., Dietterich, T.G., Lathrop, R.H., Chapman, D., Critchlow, R.E., Jr., Bauer, B.E., Webster, T.A., and Lozano-Perez, T. Compass: A shape-based machine learning tool for drug design. J. Comput.-Aided Mol. Design 1994, 8, 635-652
25. Kearsley, S.K. and Smith, G.M. An alternative method for the alignment of molecular structures: Maximizing electrostatic and steric overlap. Tetrahedron Comput. Methods 1990, 3, 615-633
26. Hermann, R.B. and Herron, D.K. OVID and SUPER: Two overlap programs for drug design. J. Comput.-Aided Mol. Design 1991, 5, 511-524
27. Good, A.C., Hodgkin, E.E., and Richards, W.G. Utilization of Gaussian functions for the rapid evaluation of molecular similarity. J. Chem. Inf. Comput. Sci. 1992, 32, 188-191
28. Sanz, F., Manaut, F., Rodríguez, J., Lozoya, E., and López-de-Briñas, E. MEPSIM: A computational package for analysis and comparison of molecular electrostatic potentials. J. Comput.-Aided Mol. Design 1993, 7, 337-347
29. Klebe, G., Mietzner, T., and Weber, F. Different approaches toward an automatic structural alignment of drug molecules: Applications to sterol mimics, thrombin and thermolysin inhibitors. J. Comput.-Aided Mol. Design 1994, 8, 751-778
30. Apaya, R.P., Lucchese, B., Price, S.L., and Vinter, J.G. The matching of electrostatic extrema: A useful method in drug design? A study of phosphodiesterase III inhibitors. J. Comput.-Aided Mol. Design 1995, 9, 33-43
31. McMartin, C. and Bohacek, R.S. Flexible matching of test ligands to a 3D pharmacophore using a molecular superposition force field: Comparison of predicted and experimental conformations of inhibitors in three enzymes. J. Comput.-Aided Mol. Design 1995, 9, 237-250
32. Perkins, T.D.J., Mills, J.E.J., and Dean, P.M. Molecular surface-volume and property matching to superpose flexible dissimilar molecules. J. Comput.-Aided Mol. Design 1995, 9, 479-490
33. Grant, J.A., Gallardo, M.A., and Pickup, B.T. A fast method of molecular shape comparison: A simple application of a Gaussian description of molecular shape. J. Comput. Chem. 1996, 17, 1653-1666
34. Mestres, J., Rohrer, D.C., and Maggiora, G.M. MIMIC: A molecular-field matching program. Exploiting the applicability of molecular similarity approaches. J. Comput. Chem. 1997, 18, 934-954
35. Mestres, J., Rohrer, D.C., and Maggiora, G.M. Submitted (1997)
36. Blaney, F., Finn, P., Phippen, R., and Wyatt, M. Molecular surface comparison: Application to drug design. J. Mol. Graphics 1993, 11, 98-105
37. Blaney, F.E., Edge, C., and Phippen, R.W. Molecular surface comparison. 2. Similarity of electrostatic vector fields in drug design. J. Mol. Graphics 1995, 13, 165-174
38. Gasteiger, J. and Li, X. Mapping the electrostatic potential of muscarinic and nicotinic agonists with artificial neural networks. Angew. Chem. Int. Ed. Engl. 1994, 33, 643-646
39. Barlow, T.W. Self-organizing maps and molecular similarity. J. Mol. Graphics 1995, 13, 24-27
40. Beck, B., Glen, R.C., and Clark, T. The inhibition of α-chymotrypsin predicted using theoretically derived molecular properties. J. Mol. Graphics 1996, 14, 130-135
41. Rohrer, D.C. 3D molecular similarity modelling in computational drug design. In: Molecular Similarity and Reactivity: From Quantum Chemical to Phenomenological Approaches (R. Carbó, ed.). Kluwer, Amsterdam, 1995, pp. 141-161
42. Mulliken atomic charges were obtained using MOPAC at the AM1 semiempirical level: Dewar, M.J.S., Zoebisch, E.G., Healy, E.F., and Stewart, J.J.P. AM1: A new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 1985, 107, 3902-3909
43. Carbó, R., Leyda, L., and Arnau, M. How similar is a molecule to another? An electron density measure of similarity between two molecular structures. Int. J. Quantum Chem. 1980, 17, 1185-1189
44. Hodgkin, E.E. and Richards, W.G. Molecular similarity based on electrostatic potential and electric field. Int. J. Quantum Chem. Quantum Biol. Symp. 1987, 14, 105-110
45. Petke, J. Cumulative and discrete similarity analysis of electrostatic potentials and fields. J. Comput. Chem. 1993, 14, 928-933
46. Good, A.C. The calculation of molecular similarity: Alternative formulas, data manipulation and graphical display. J. Mol. Graphics 1992, 10, 144-151
47. Reynolds, C.A., Burt, C., and Richards, W.G. A linear molecular similarity index. Quant. Struct.-Act. Relat. 1992, 11, 34-35
48. Kempf, D.J. and Sham, H.L. HIV protease inhibitors. Curr. Pharm. Design 1996, 2, 225-246
49. Waller, C.L., Oprea, T.I., Giolitti, A., and Marshall, G.R. Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules. J. Med. Chem. 1993, 36, 4152-4160
50. Oprea, T.I., Waller, C.L., and Marshall, G.R. Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus (I) protease inhibitors. 2. Predictive power using limited exploration of alternate binding modes. J. Med. Chem. 1994, 37, 2206-2215
51. Oprea, T.I., Waller, C.L., and Marshall, G.R. 3D-QSAR of human immunodeficiency virus (I) protease inhibitors. 3. Interpretation of CoMFA results. Drug Design Discov. 1994, 12, 29-51
52. Rohrer, D.C. 3D molecular similarity methods: In search of a pharmacophore. In: Experimental and Computational Approaches to Structure-Based Drug Design (P.W. Codding, ed.). Kluwer, Amsterdam, 1997 (in press)
53. Thanki, N., Rao, J.K.M., Foundling, S.I., Howe, W.J., Moon, J.B., Hui, J.O., Tomasselli, A.G., Heinrikson, R.L., Thaisrivongs, S., and Wlodawer, A. Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: Comparisons with molecular modeling. Protein Sci. 1992, 1, 1061-1072
54. Kim, E.E., Baker, C.T., Dwyer, M.D., Murcko, M.A., Rao, B.G., Tung, R.D., and Navia, M.A. Crystal structure of HIV-1 protease in complex with VX-478, a potent and orally bioavailable inhibitor of the enzyme. J. Am. Chem. Soc. 1995, 117, 1181-1182
55. Swain, A.L., Miller, M.M., Green, J., Rich, D.H., Schneider, J., Kent, S.B.H., and Wlodawer, A. X-Ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 8805-8809
56. 2 symmetric inhibitor complexed to HIV-1 protease. Science 1990, 249, 527-533
57. For a discussion on the comparative ability of molecular field similarity approaches to assess the correct relative binding model when using crystal structures directly or when dealing with a set of representative structures derived from conformational analysis, see Ref. 35
58. Bernstein, F., Koetzle, T., Williams, G., Meyer, E., Brice, M., Rodgers, J., Kennard, O., Shimanoushi, T., and Tasumi, M. The Protein Data Bank: A computer-based archival file for macromolecular structures. J. Mol. Biol. 1977, 112, 535-542
59. {M} is optimized and, consequently, the relative orientation of all molecules is rearranged, the final best multimolecule alignment should not be dependent on the molecule selected as the reference molecule
60. Binding pocket nomenclature according to: Schecter, I. and Berger, A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 1967, 27, 157-162